---

Platelet-rich plasma for treatment of rheumatoid arthritis

Full Text PDF

---

Editorial

Author Details : Ashim Gupta*, Manish Khanna

Volume : 8, Issue : 2, Year : 2022

Article Page : 44-46

https://doi.org/10.18231/j.ijor.2022.011

Suggest article by email

Get Permission

Abstract

Rheumatoid Arthritis (RA) is a chronic, inflammatory, autoimmune ailment which involves joint pathogenesis, bone and cartilage irregularities, together with systemic comorbidities, impacting over 75 million people worldwide. At present there is no remedy for RA and the existing treatment modalities utilized have shortcomings and side effects. Recently, there has been an increased interest in use of biologics, such as platelet-rich plasma (PRP), for regenerative medicine applications, including for musculoskeletal ailments. This prompted consideration of use of PRP in patients suffering with RA. In this editorial, we highlighted the safety and efficacy of PRP to treat RA based on recently published clinical studies. These studies, despite preliminary, demonstrated that use of PRP is safe and laid the foundation for multi-center prospective open-label non-randomized trials and double-blinded randomized controlled trials with larger sample size to further evaluate the efficacy of PRP to alleviate symptoms of RA for potential clinical usage.
 

Keywords: Rheumatoid arthritis, clinical trials, Platelet­rich plasma, PRP

How to cite : Gupta A, Khanna M, Platelet-rich plasma for treatment of rheumatoid arthritis. IP Int J Orthop Rheumatol 2022;8(2):44-46

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution 4.0 International License, which allows others to remix, and build upon the work, the licensor cannot revoke these freedoms as long as you follow the license terms.